MX2023012514A - Materiales y metodos para fosfotransferasas mejoradas. - Google Patents
Materiales y metodos para fosfotransferasas mejoradas.Info
- Publication number
- MX2023012514A MX2023012514A MX2023012514A MX2023012514A MX2023012514A MX 2023012514 A MX2023012514 A MX 2023012514A MX 2023012514 A MX2023012514 A MX 2023012514A MX 2023012514 A MX2023012514 A MX 2023012514A MX 2023012514 A MX2023012514 A MX 2023012514A
- Authority
- MX
- Mexico
- Prior art keywords
- npt
- naturally occurring
- proteins
- protein
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
- C12Y207/01095—Kanamycin kinase (2.7.1.95), i.e. neomycin-kanamycin phosphotransferase
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163177759P | 2021-04-21 | 2021-04-21 | |
| US202163177746P | 2021-04-21 | 2021-04-21 | |
| US202163177739P | 2021-04-21 | 2021-04-21 | |
| US202163177749P | 2021-04-21 | 2021-04-21 | |
| US202163177767P | 2021-04-21 | 2021-04-21 | |
| US202163177764P | 2021-04-21 | 2021-04-21 | |
| US202163177753P | 2021-04-21 | 2021-04-21 | |
| US202163177744P | 2021-04-21 | 2021-04-21 | |
| PCT/US2022/025452 WO2022226005A1 (en) | 2021-04-21 | 2022-04-20 | Materials and methods for improved phosphotransferases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023012514A true MX2023012514A (es) | 2024-01-05 |
Family
ID=83722653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023012514A MX2023012514A (es) | 2021-04-21 | 2022-04-20 | Materiales y metodos para fosfotransferasas mejoradas. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240191215A1 (https=) |
| EP (1) | EP4326747A4 (https=) |
| JP (1) | JP2024516153A (https=) |
| KR (1) | KR20230173159A (https=) |
| AU (1) | AU2022261882A1 (https=) |
| BR (1) | BR112023021960A2 (https=) |
| CA (1) | CA3217224A1 (https=) |
| IL (1) | IL307870A (https=) |
| MX (1) | MX2023012514A (https=) |
| TW (1) | TW202305127A (https=) |
| WO (1) | WO2022226005A1 (https=) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7344886B2 (en) * | 2002-11-29 | 2008-03-18 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Neomycin-phosphotransferase-genes and methods for the selection of recombinant cells producing high levels of a desired gene product |
| KR101149777B1 (ko) * | 2002-11-29 | 2012-06-11 | 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 | 신규한 네오마이신 포스포트랜스퍼라제 유전자 및 고생산성 재조합 세포의 선별 방법 |
| US20080124760A1 (en) * | 2006-07-26 | 2008-05-29 | Barbara Enenkel | Regulatory Nucleic Acid Elements |
| EP1975228A1 (en) * | 2007-03-28 | 2008-10-01 | Fachhochschule Mannheim | Polynucleotides for enhancing expression of a polynucleotide of interest |
| AU2011342162B2 (en) * | 2010-12-15 | 2017-04-20 | Kyowa Kirin Co., Ltd. | Method for producing proteins |
| US11389531B2 (en) * | 2017-12-19 | 2022-07-19 | Janssen Sciences Ireland Unlimited Company | Methods and apparatus for the delivery of hepatitis B virus (HBV) vaccines |
-
2022
- 2022-04-20 CA CA3217224A patent/CA3217224A1/en active Pending
- 2022-04-20 US US18/287,742 patent/US20240191215A1/en active Pending
- 2022-04-20 MX MX2023012514A patent/MX2023012514A/es unknown
- 2022-04-20 IL IL307870A patent/IL307870A/en unknown
- 2022-04-20 AU AU2022261882A patent/AU2022261882A1/en not_active Abandoned
- 2022-04-20 WO PCT/US2022/025452 patent/WO2022226005A1/en not_active Ceased
- 2022-04-20 BR BR112023021960A patent/BR112023021960A2/pt not_active Application Discontinuation
- 2022-04-20 JP JP2023564448A patent/JP2024516153A/ja active Pending
- 2022-04-20 EP EP22792366.1A patent/EP4326747A4/en active Pending
- 2022-04-20 KR KR1020237039725A patent/KR20230173159A/ko active Pending
- 2022-04-20 TW TW111114949A patent/TW202305127A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3217224A1 (en) | 2022-10-27 |
| US20240191215A1 (en) | 2024-06-13 |
| IL307870A (en) | 2023-12-01 |
| TW202305127A (zh) | 2023-02-01 |
| JP2024516153A (ja) | 2024-04-12 |
| WO2022226005A1 (en) | 2022-10-27 |
| EP4326747A1 (en) | 2024-02-28 |
| EP4326747A4 (en) | 2025-06-11 |
| AU2022261882A1 (en) | 2023-12-07 |
| BR112023021960A2 (pt) | 2023-12-26 |
| KR20230173159A (ko) | 2023-12-26 |
| AU2022261882A9 (en) | 2023-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20190072639A (ko) | 세포 치료에 사용하기 위한 면역학적으로 식별 가능한 세포 표면 변이체 | |
| PH12020551039A1 (en) | Non-viral dna vectors and uses thereof for antibody and fusion protein production | |
| EP3938501A1 (en) | Pooled knock-in screening and heterologous polypeptides co-expressed under the control of endogenous loci | |
| EP1171588A1 (en) | P element derived vector and methods for its use | |
| US20220098565A1 (en) | Process for making recombinant antidote to factor xa inhibitor | |
| Jeannotte et al. | Low level of Hox1. 3 gene expression does not preclude the use of promoterless vectors to generate a targeted gene disruption | |
| CN112955549A (zh) | 改进的高通量组合基因修饰系统和优化的Cas9酶变体 | |
| CN116783296A (zh) | 用于募集adar的向导rna的筛选平台 | |
| MX2023012514A (es) | Materiales y metodos para fosfotransferasas mejoradas. | |
| JPWO2012147370A1 (ja) | ターミネータ配列を含む高発現用リバースプライマー及びリニアｄｎａ | |
| CN106319638B (zh) | 毕赤酵母内源信号肽及其应用 | |
| Dong et al. | Cas12a/Cpf1 knock-in mice enable efficient multiplexed immune cell engineering | |
| US20170166904A1 (en) | Method for producing vector in which foreign gene has been introduced | |
| FI3615674T3 (fi) | Menetelmiä reumatoidin artriitin hoitoon HLA-geenin RNA-ohjattua genomin muokkausta käyttämällä | |
| EP4458963A1 (en) | Highly active crispr base editors obtained through cas-assisted substrate-linked directed evolution (caslide) | |
| KR102576635B1 (ko) | Lamp2c 유전자가 녹아웃 된 형질전환 인간 세포주 및 이를 이용한 목적 유전자의 생산 방법 | |
| KR101947869B1 (ko) | 차세대 시퀀싱 기반 재조합 단백질 발현을 위한 세포 내 핫스팟 영역 탐색 방법 | |
| WO2002072821A3 (en) | Method for indentification of cdnas encoding signal peptides | |
| JP2023544161A (ja) | がんの改善されたｔ細胞免疫療法のためのｄｎａ構築物 | |
| US11814644B2 (en) | Extrachromosomal switching auxotrophies progressively by integration (eSwAP-In) for assembly of DNA sequences in yeast | |
| Widekdo et al. | Effect of Combination of Different Antibiotics and Promoters for Expressing Recombinant Darbepoetin in Stable CHO K-1 Cell Line. | |
| US9127285B2 (en) | Genetically altered ciliates and uses thereof | |
| KR101542139B1 (ko) | 세포 간 단백질 전달을 위한 세포외로 분비되는 호메오도메인 전사인자 스크리닝 방법 | |
| US20220145286A1 (en) | Barcoded clonal tracking of gene targeting in cells | |
| KR20260034618A (ko) | 털매머드 특이적 유전자 변이체 및 이를 포함하는 조성물 |